Our previous studies suggested that increase Cisd2 levels may attenuate the pathogenesis of NAFLD/NASH. Accordingly, potent Cisd2 activators with the capacity to enhance Cisd2 levels were identified through the screening of skeletally diverse collections and structural optimization. So far BPRCD0001S0 is the most potent Cisd2 activator obtained, which has been studied extensively. Data obtained revealed that BPRCD0001S0 has no detectable toxicity in vivo, can activate Cisd2 in liver and ameliorate obese-related and fructose-induced NAFLD/NASH.

This technology is mainly solved the side effects of anti-obesity drug, including soft stoolsoily stools,regulate oil absorptionmetabolism as an additive in food. During the experiment, the curing phenomenon of MSNs/oiloily stool reduction in animal were observed. In conclusion, MSNs can effectively reduce the side effects of Orlistatelevating life quality.

The HeaortaNet is developed by the TW-CVAI team. The HeaortaNet is a deep learning model trained by 70,000 axial images from 200 patients with verified annotations of the pericardiumaorta. It shortens the time for data processing from 60 minutes, by manual segmentation of both pericardiumaorta, to 0.4 seconds. The segmentation accuracy, as assessed by dice similarity coefficient, is 94.8 for the pericardium,91.6 for the aorta. The imaging-based Cardiovascular Risk Prediction module was constructed by analyzing data from the National Health Insurance Databank.

Currently, unmet clinical needs of nonsurgical high-intensity focused ultrasound (HIFU) fat reduction are a long time to see the fat reduction after HIFU lipolysis, long treatment time,low treatment efficacy. The porcine study has corroborated that the ultrasonic fast-shaping system can generate a strip-shape focal zone to form a line-shape hot spot, shortening treatment timeincreasing the amounts of lysed adipocytes,combine with the passive exercise to accelerate metabolism of the free lipids from necrotic adipocytes, improving the reduction in the waist circumferences.

PPARγ is the master regulator of glucose metabolism.15-keto-PGE2 is an endogenous PPARγ ligand whitch is degraded by ZADH1. We found that increasing 15-keto-PGE2 promotes glucose uptake. We identified several ZADH1 inhibitors which could increase 15-keto-PGE2 promote glucose uptake via activating PPARγ. Our results showed that inhibition of ZADH1 is a novel approach to treat type 2 diabes mell